The University of Health and Allied Sciences (UHAS) has hosted a capacity-building session for participants of the Oncology Nursing Leadership Programme (ONLEP) and the university’s student body, ...

Brian Hodous, Ph.D., promoted to chief scientific officer-- Vivek Kadambi, Ph.D., joins Recludix as senior vice president of non-clinical scienc ...

Ohio’s bioscience boom is a success story for our economy and patient care. However, Ohio’s elected leaders need to reject ...

Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will ...

The Oncology Nurse Leadership Programme (ONLEP) was officially launched at the University of Health and Allied Sciences (UHAS) on Monday, July 7, 2025.

New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...

Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building an ...

Celltrion USA announced that Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo), biosimilars referencing Prolia ...

Celltrion USA today announced that STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo), biosimilars referencing PROLIA® ...

Stoboclo and Osenvelt, FDA-approved biosimilars of Prolia and Xgeva, are now available in the U.S. for variois cancers and ...

Abdera Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable precision radiopharmaceuticals for ...